Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 52, 106-111
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Peripheral Mechanisms in Irritable Bowel SyndromeNew England Journal of Medicine, 2012
- Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With DiarrheaClinical Gastroenterology and Hepatology, 2012
- A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic ConstipationAmerican Journal of Gastroenterology, 2011
- Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic AnalysisGastroenterology, 2010
- Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea‐predominant irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2009
- Current and novel therapeutic options for irritable bowel syndrome managementDigestive and Liver Disease, 2009
- Measurement of serum 7α‐hydroxy‐4‐cholesten‐3‐one (or 7αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography‐tandem mass spectrometryNeurogastroenterology & Motility, 2009
- Functional Bowel DisordersGastroenterology, 2006
- Bile Acid Synthesis in Humans Has a Rapid Diurnal Variation That Is Asynchronous With Cholesterol SynthesisGastroenterology, 2005
- Serum 7α-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoeaEuropean Journal of Gastroenterology & Hepatology, 1996